{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:04:20Z","timestamp":1790413460088,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10096-018-3325-4","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T07:36:14Z","timestamp":1531985774000},"page":"1915-1922","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adjunctive interferon-\u03b3 immunotherapy in a pediatric case of Aspergillus terreus infection"],"prefix":"10.1007","volume":"37","author":[{"given":"Eemke L.","family":"Assendorp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Gresnigt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien G. G.","family":"Sprenkeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasja","family":"Dors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan W. M.","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie S. V.","family":"Henriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"issue":"8","key":"3325_CR1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","volume":"50","author":"DP Kontoyiannis","year":"2010","unstructured":"Kontoyiannis DP, Marr KA, Park BJ et al (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50(8):1091\u20131100","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3325_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/jpids\/piu074","volume":"4","author":"RL Wattier","year":"2015","unstructured":"Wattier RL, Dvorak CC, Hoffman JA et al (2015) A prospective, international cohort study of invasive mold infections in children. J Pediatric Infect Dis Soc 4(4):313\u2013322","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"2","key":"3325_CR3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1086\/421950","volume":"39","author":"WJ Steinbach","year":"2004","unstructured":"Steinbach WJ, Benjamin DK Jr, Kontoyiannis DP et al (2004) Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clin Infect Dis 39(2):192\u2013198","journal-title":"Clin Infect Dis"},{"issue":"12","key":"3325_CR4","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1128\/JCM.41.12.5525-5529.2003","volume":"41","author":"JW Baddley","year":"2003","unstructured":"Baddley JW, Pappas PG, Smith AC et al (2003) Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 41(12):5525\u20135529","journal-title":"J Clin Microbiol"},{"issue":"6","key":"3325_CR5","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/myc.12081","volume":"56","author":"RE Lewis","year":"2013","unstructured":"Lewis RE, Cahyame-Zuniga L, Leventakos K et al (2013) Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses 56(6):638\u2013645","journal-title":"Mycoses"},{"issue":"5","key":"3325_CR6","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1086\/520297","volume":"26","author":"PC Iwen","year":"1998","unstructured":"Iwen PC, Rupp ME, Langnas AN et al (1998) Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin Infect Dis 26(5):1092\u20131097","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3325_CR7","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1086\/323900","volume":"33","author":"JR Perfect","year":"2001","unstructured":"Perfect JR, Cox GM, Lee JY et al (2001) The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 33(11):1824\u20131833","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3325_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/00006454-199308000-00009","volume":"12","author":"S Walmsley","year":"1993","unstructured":"Walmsley S, Devi S, King S et al (1993) Invasive Aspergillus infections in a pediatric hospital: a ten-year review. Pediatr Infect Dis J 12(8):673\u2013682","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl1","key":"3325_CR9","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.3109\/13693786.2010.499916","volume":"49","author":"JW Linden Van Der","year":"2011","unstructured":"Van Der Linden JW, Warris A, Verweij PE (2011) Aspergillus species intrinsically resistant to antifungal agents. Med Mycol 49(Suppl1):S82\u2013S89","journal-title":"Med Mycol"},{"issue":"3","key":"3325_CR10","doi-asserted-by":"publisher","first-page":"e0118997","DOI":"10.1371\/journal.pone.0118997","volume":"10","author":"S Kathuria","year":"2015","unstructured":"Kathuria S, Sharma C, Singh PK et al (2015) Molecular epidemiology and in-vitro antifungal susceptibility of Aspergillus terreus species complex isolates in Delhi, India: evidence of genetic diversity by amplified fragment length polymorphism and microsatellite typing. PLoS One 10(3):e0118997","journal-title":"PLoS One"},{"issue":"10","key":"3325_CR11","doi-asserted-by":"publisher","first-page":"776.e1","DOI":"10.1016\/j.cmi.2017.04.012","volume":"23","author":"B Rissleger","year":"2017","unstructured":"Rissleger B, Zoran T, Lackner M et al (2017) A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study. Clin Microbiol Infect 23(10):776.e1\u2013776.e5","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3325_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijantimicag.2014.07.002","volume":"44","author":"FJ Pastor","year":"2014","unstructured":"Pastor FJ, Guarro J (2014) Treatment of Aspergillus terreus infections: a clinical problem not yet resolved. Int J Antimicrob Agents 44(4):281\u2013289","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"3325_CR13","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1002\/cncr.20554","volume":"101","author":"RY Hachem","year":"2004","unstructured":"Hachem RY, Kontoyiannis DP, Boktour MR et al (2004) Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies. Cancer 101(7):1594\u20131600","journal-title":"Cancer"},{"issue":"2","key":"3325_CR14","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2141.2005.05763.x","volume":"131","author":"C Lass-Florl","year":"2005","unstructured":"Lass-Florl C, Griff K, Mayr A et al (2005) Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 131(2):201\u2013207","journal-title":"Br J Haematol"},{"issue":"11","key":"3325_CR15","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.1093\/jac\/dku241","volume":"69","author":"R Hachem","year":"2014","unstructured":"Hachem R, Gomes MZ, El Helou G et al (2014) Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy. J Antimicrob Chemother 69(11):3148\u20133155","journal-title":"J Antimicrob Chemother"},{"issue":"9881","key":"3325_CR16","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","volume":"381","author":"H Inaba","year":"2013","unstructured":"Inaba H, Greaves M, Mullighan CG (2013) Acute lymphoblastic leukaemia. Lancet 381(9881):1943\u20131955","journal-title":"Lancet"},{"key":"3325_CR17","unstructured":"Treatment study protocol of the Dutch Childhood Oncology Group for children and adolescents (1-19\u00a0year) with newly diagnosed acute lymphoblastic leukemia (2017) DCOG ALL-11 Protocol committee"},{"issue":"12","key":"3325_CR18","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/S1473-3099(17)30442-5","volume":"17","author":"D Armstrong-James","year":"2017","unstructured":"Armstrong-James D, Brown GD, Netea MG et al (2017) Immunotherapeutic approaches to treatment of fungal diseases. Lancet Infect Dis 17(12):e393\u2013e402","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"3325_CR19","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1086\/315142","volume":"180","author":"E Cenci","year":"1999","unstructured":"Cenci E, Mencacci A, Del Sero G et al (1999) Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 180(6):1957\u20131968","journal-title":"J Infect Dis"},{"issue":"8","key":"3325_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"Group TICGDCS","year":"1991","unstructured":"Group TICGDCS (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324(8):509\u2013516","journal-title":"N Engl J Med"},{"issue":"1","key":"3325_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1086\/517077","volume":"26","author":"CH Poynton","year":"1998","unstructured":"Poynton CH, Barnes RA, Rees J (1998) Interferon gamma and granulocyte-macrophage colony-stimulating factor for the treatment of hepatosplenic candidosis in patients with acute leukemia. Clin Infect Dis 26(1):239\u2013240","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3325_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cncr.21142","volume":"104","author":"MC Dignani","year":"2005","unstructured":"Dignani MC, Rex JH, Chan KW et al (2005) Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia. Cancer 104(1):199\u2013204","journal-title":"Cancer"},{"key":"3325_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1471-2334-14-166","volume":"14","author":"CE Delsing","year":"2014","unstructured":"Delsing CE, Gresnigt MS, Leentjes J et al (2014) Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series. BMC Infect Dis 14:166","journal-title":"BMC Infect Dis"},{"issue":"6","key":"3325_CR24","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","volume":"172","author":"H Nagai","year":"1995","unstructured":"Nagai H, Guo J, Choi H et al (1995) Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis 172(6):1554\u20131560","journal-title":"J Infect Dis"},{"issue":"2","key":"3325_CR25","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/infdis\/168.2.436","volume":"168","author":"BJ Kullberg","year":"1993","unstructured":"Kullberg BJ, van 't Wout JW, Hoogstraten C et al (1993) Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 168(2):436\u2013443","journal-title":"J Infect Dis"},{"issue":"2","key":"3325_CR26","doi-asserted-by":"publisher","first-page":"e4588","DOI":"10.1371\/journal.pone.0004588","volume":"4","author":"MA Al-Zeer","year":"2009","unstructured":"Al-Zeer MA, Al-Younes HM, Braun PR et al (2009) IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy. PLoS One 4(2):e4588","journal-title":"PLoS One"},{"issue":"11","key":"3325_CR27","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.4161\/auto.21403","volume":"8","author":"DV Kalvakolanu","year":"2012","unstructured":"Kalvakolanu DV, Gade P (2012) IFNG and autophagy: a critical role for the ER-stress mediator ATF6 in controlling bacterial infections. Autophagy 8(11):1673\u20131674","journal-title":"Autophagy"},{"issue":"1","key":"3325_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imm.12062","volume":"139","author":"GM Klug-Micu","year":"2013","unstructured":"Klug-Micu GM, Stenger S, Sommer A et al (2013) CD40 ligand and interferon-gamma induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes. Immunology 139(1):121\u2013128","journal-title":"Immunology"},{"key":"3325_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.biocel.2014.08.022","volume":"55","author":"G Sharma","year":"2014","unstructured":"Sharma G, Dutta RK, Khan MA et al (2014) IL-27 inhibits IFN-gamma induced autophagy by concomitant induction of JAK\/PI3 K\/Akt\/mTOR cascade and up-regulation of Mcl-1 in Mycobacterium tuberculosis H37Rv infected macrophages. Int J Biochem Cell Biol 55:335\u2013347","journal-title":"Int J Biochem Cell Biol"},{"issue":"9","key":"3325_CR30","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1111\/cmi.12616","volume":"18","author":"EG Sprenkeler","year":"2016","unstructured":"Sprenkeler EG, Gresnigt MS, van de Veerdonk FL (2016) LC3-associated phagocytosis: a crucial mechanism for antifungal host defence against Aspergillus fumigatus. Cell Microbiol 18(9):1208\u20131216","journal-title":"Cell Microbiol"},{"issue":"8","key":"3325_CR31","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJM199102213240801","volume":"324","author":"The International Chronic Granulomatous Disease Cooperative Study Group","year":"1991","unstructured":"The International Chronic Granulomatous Disease Cooperative Study Group (1991) A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324(8):509\u2013516","journal-title":"N Engl J Med"},{"issue":"5","key":"3325_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1086\/422993","volume":"39","author":"BE Marciano","year":"2004","unstructured":"Marciano BE, Wesley R, De Carlo ES et al (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39(5):692\u2013699","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3325_CR33","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1111\/j.1600-6143.2010.03094.x","volume":"10","author":"D Armstrong-James","year":"2010","unstructured":"Armstrong-James D, Teo IA, Shrivastava S et al (2010) Exogenous interferon-gamma immunotherapy for invasive fungal infections in kidney transplant patients. Am J Transplant 10(8):1796\u20131803","journal-title":"Am J Transplant"},{"issue":"6","key":"3325_CR34","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/eci.12448","volume":"45","author":"M Arvanitis","year":"2015","unstructured":"Arvanitis M, Mylonakis E (2015) Diagnosis of invasive aspergillosis: recent developments and ongoing challenges. Eur J Clin Investig 45(6):646\u2013652","journal-title":"Eur J Clin Investig"},{"issue":"6","key":"3325_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3201\/eid2106.140717","volume":"21","author":"JW Linden Van der","year":"2015","unstructured":"Van der Linden JW, Arendrup MC, Warris A et al (2015) Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus. Emerg Infect Dis 21(6):1041\u20131044","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"3325_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1473-3099(15)70006-X","volume":"15","author":"S Schelenz","year":"2015","unstructured":"Schelenz S, Barnes RA, Barton RC et al (2015) British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis 15(4):461\u2013474","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"3325_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1200\/JCO.2014.58.0480","volume":"33","author":"D Chellapandian","year":"2015","unstructured":"Chellapandian D, Lehrnbecher T, Phillips B et al (2015) Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis. J Clin Oncol 33(5):501\u2013509","journal-title":"J Clin Oncol"},{"key":"3325_CR38","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13052-016-0239-6","volume":"42","author":"TF Weng","year":"2016","unstructured":"Weng TF, Wu KH, Wu HP et al (2016) Changes of serum Aspergillus galactomannan during hematopoietic stem cell transplantation in children with prior invasive aspergillosis. Ital J Pediatr 42:30","journal-title":"Ital J Pediatr"},{"issue":"6","key":"3325_CR39","doi-asserted-by":"publisher","first-page":"e0129022","DOI":"10.1371\/journal.pone.0129022","volume":"10","author":"D Neofytos","year":"2015","unstructured":"Neofytos D, Railkar R, Mullane KM et al (2015) Correlation between circulating fungal biomarkers and clinical outcome in invasive aspergillosis. PLoS One 10(6):e0129022","journal-title":"PLoS One"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3325-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3325-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T23:13:38Z","timestamp":1563491618000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3325-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,19]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["3325"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3325-4","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,19]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"J.F.M. received grants from Astellas, Merck, and Basilea. He has been a consultant to Basilea Scynexis and Merck and received speaker fees from Merck, Pfizer, Gilead, TEVA, and United Medical. All other authors declare they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}